275.80
-0.72%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Getinge
Its shares trade on Nasdaq Stockholm under the ticker GETI B.ST. It has been listed since 8 June 1995. In the fiscal year to 31 December 2025, it reported revenue of SEK 34.97bn and net income of SEK 2.26bn. At that date it held total assets of SEK 56.51bn and shareholders' equity of SEK 29.43bn.
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands. The company provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The firm's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Jun 1995
- Employees
- 10,746
- Website
- getingegroup.com ↗
Leadership
Pay as last reported
- Mr. Johan MalmquistIndependent Chairman of the Board, since 1997SEK 1.8m
- Mr. Mattias PerjosPresident, Chief Executive Officer, Director, since 2017SEK 59.8m
- Mr. Carl BennetVice Chairman of the BoardSEK 816,600
- Ms. Agneta PalmerChief Financial Officer
- Ms. Elin FrostehavPresident - Acute Care Therapies
- Mr. Eric HonrothPresident - Life Science
- Mr. Stephane Le RoyPresident - Surgical Workflows
- Mr. Magnus LundbaeckExecutive Vice President - Human Resources
- Ms. Joanna EngelkeExecutive Vice President - Quality Compliance, Regulatory and Medical Affairs
- Ms. Alexandra HollandExecutive Vice President - Communications
- Ms. Anna RombergExecutive Vice President - Sustainability, Legal and Compliance
- Mr. Carsten BleckerChief Commercial Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 75
- Environment
- 76
- Social
- 80
- Governance
- 69
- Direct emissions (scope 1)
- 15,532 t
- Energy emissions (scope 2)
- 3,901 t
- Value chain emissions (scope 3)
- 614,508 t
- Women in the workforce
- 38%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Established market presence: Getinge AB is a well-known and reputable company within the medical technology industry.
- Diverse product portfolio: The company offers a wide range of medical devices and equipment, catering to various healthcare needs.
- Strong research and development capabilities: Getinge invests heavily in R&D, enabling them to continuously innovate and introduce new products.
Weaknesses
- Dependence on key markets: Getinge relies heavily on certain regions for its revenue, making it vulnerable to economic fluctuations in those markets.
- High production costs: The company's manufacturing processes can be expensive, affecting its profit margins.
- Limited presence in emerging markets: Getinge has relatively lower market penetration in developing countries compared to its competitors.
Opportunities
- Increasing healthcare expenditure: As global healthcare spending continues to rise, Getinge can benefit from increased demand for medical devices and equipment.
- Growing aging population: The aging population across the world presents an opportunity for Getinge to provide specialized healthcare solutions.
- Expansion into emerging markets: The company can focus on expanding its presence in developing countries where there is a growing demand for healthcare solutions.
Threats
- Intense competition: Getinge operates in a highly competitive industry, facing competition from both established players and emerging startups.
- Stringent regulatory environment: Compliance with stringent regulations can pose challenges for Getinge in terms of product development and market approvals.
- Technological advancements: Rapid technological advancements may make existing products obsolete, requiring continuous investment in innovation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.